Short answer · Medically reviewed summary · Last updated: 2026-05-08
Polycystic Liver Disease (PLD) is considered a rare condition, with an estimated prevalence ranging from 1 in 10,000 to 1 in 100,000 individuals in the general population, though these figures are likely underestimates due to many asymptomatic cases. While often associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD), isolated Polycystic Liver Disease presents as a distinct genetic entity with a strong female predilection. Is Polycystic Liver Disease common or rare? Polycystic Liver Disease is classified as a rare disorder.
What is the prevalence of Polycystic Liver Disease?
Prevalence of Polycystic Liver Disease: how many people are affected worldwide, differences by sex and region, with sources.
Polycystic Liver Disease (PLD) is considered a rare condition, with an estimated prevalence ranging from 1 in 10,000 to 1 in 100,000 individuals in the general population, though these figures are likely underestimates due to many asymptomatic cases. While often associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD), isolated Polycystic Liver Disease presents as a distinct genetic entity with a strong female predilection.
Is Polycystic Liver Disease common or rare?
Polycystic Liver Disease is classified as a rare disorder. Accurate prevalence is difficult to determine because many individuals remain asymptomatic throughout their lives and are never clinically diagnosed. While clinical registries and autopsy studies provide some data, the true global burden of Polycystic Liver Disease remains under-reported. In our DiseaseMaps.org community, we currently support 7 individuals navigating the complexities of Polycystic Liver Disease, reflecting the niche yet significant impact this diagnosis has on patient lives.
Does gender or age affect Polycystic Liver Disease risk?
Clinical data consistently shows that Polycystic Liver Disease disproportionately affects females. Research suggests that estrogen may play a role in the growth and progression of hepatic cysts, which explains why women often present with more severe symptoms, particularly during their reproductive years. Regarding age, the condition is rarely diagnosed in childhood. Most patients with Polycystic Liver Disease begin to manifest symptoms or are identified through imaging during early to middle adulthood, typically between the ages of 30 and 50.
What are the primary challenges in tracking this disease?
The epidemiological landscape of Polycystic Liver Disease is complicated by several factors:
- Asymptomatic presentation: Many patients have small, stable cysts that never interfere with liver function.
- Diagnostic overlap: It is frequently identified incidentally during screenings for other conditions, such as ADPKD.
- Genetic heterogeneity: Isolated Polycystic Liver Disease is often caused by mutations in the PRKCSH or SEC63 genes, which may be missed in broader genetic panels.
Next steps
- Consult a hepatologist or a geneticist to discuss your clinical presentation and potential genetic testing.
- Monitor liver function regularly through ultrasound or MRI if you have a family history of cystic disease.
- Connect with the 7 members at DiseaseMaps.org who are currently sharing their experiences with Polycystic Liver Disease.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.
References
- Orphanet: Polycystic liver disease (ORPHA:293915).
- NIH Genetic and Rare Diseases Information Center (GARD): Polycystic liver disease.
- Online Mendelian Inheritance in Man (OMIM): Polycystic liver disease 1 (PSCL1).
- PubMed: "Epidemiology and clinical management of polycystic liver disease" (Review articles).
